MGB Makes Minimal Movement and Ends Talks Share Post Post navigation Previous PostInnovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye DiseaseNext Post The Inner Circle acknowledges Dr. Reuben Azad as a Pinnacle Lifetime Member Inner Circle of Excellence